Semagacestat

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameSemagacestat
Drug Alias Name司马西特semagacestat塞美司他semagacestatum瑟伽司他 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-secretase inhibitors
TargetsGamma-secretase
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumBulgariaCanada +[31] 
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaPending
Originator CompaniesEli Lilly And CompanyPerrigo Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEli Lilly And Company
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG